BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4319 related articles for article (PubMed ID: 4133186)

  • 1. In vitro methods to complement in vivo approaches utilizing combinations of chemotherapy and immunotherapy.
    Sigel MM; Lichter W; Lopez DM
    Cancer Chemother Rep 2; 1974 Mar; 4(1):109-14. PubMed ID: 4133186
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination therapy: some concepts and results.
    Skipper HE
    Cancer Chemother Rep 2; 1974 Mar; 4(1):137-45. PubMed ID: 4363649
    [No Abstract]   [Full Text] [Related]  

  • 3. [Selective tumour chemotherapy using oncobiograms (author's transl)].
    Volm M; Kaufmann M; Wayss K; Goerttler K; Mattern J
    Dtsch Med Wochenschr; 1974 Jan; 99(2):38-43. PubMed ID: 4129485
    [No Abstract]   [Full Text] [Related]  

  • 4. Rationale of combination chemotherapy based on preclinical experiments.
    Goldin A
    Cancer Chemother Rep 3; 1973 Mar; 4(2):189-98. PubMed ID: 4580857
    [No Abstract]   [Full Text] [Related]  

  • 5. New agents and combinations in the treatment of bronchogenic carcinoma.
    Bodey GP; Gottlieb JA; Livingston R; Frei E
    Cancer Chemother Rep 3; 1973 Mar; 4(2):227-9. PubMed ID: 4125740
    [No Abstract]   [Full Text] [Related]  

  • 6. Biochemical aspects of drug combinations.
    Brockman RW
    Cancer Chemother Rep 2; 1974 Mar; 4(1):115-29. PubMed ID: 4135108
    [No Abstract]   [Full Text] [Related]  

  • 7. Potentially useful combinations of chemotherapy detected in mouse tumor systems.
    Kline I
    Cancer Chemother Rep 2; 1974 Mar; 4(1):33-43. PubMed ID: 4133187
    [No Abstract]   [Full Text] [Related]  

  • 8. Cellular heterogeneity in malignant tumors. The importance of clonal interaction on tumor evolution, response to chemotherapy and metastatic ability evaluated in experimental systems.
    Aabo K
    Dan Med Bull; 1996 Sep; 43(4):336-49. PubMed ID: 8884135
    [No Abstract]   [Full Text] [Related]  

  • 9. The immunotherapy of cancer.
    Parker CW
    Pharmacol Rev; 1973 Jun; 25(2):325-42. PubMed ID: 4581047
    [No Abstract]   [Full Text] [Related]  

  • 10. Approaches to combination chemotherapy in rat, mouse, and hamster tumors.
    Griswold DP; Dykes DJ; Kelley CA; Roberts BJ; Dominick CA
    Cancer Chemother Rep 2; 1974 Mar; 4(1):99-108. PubMed ID: 4524043
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cancer and the lymphatic system].
    Grekh IF
    Vopr Onkol; 1971 Sep; 17(10):101-10. PubMed ID: 4947716
    [No Abstract]   [Full Text] [Related]  

  • 12. [Modern methods of therapeutic management of malignant proliferative disorders].
    Sroczyński J
    Wiad Lek; 1974 Nov; 27(22):1977-83. PubMed ID: 4613011
    [No Abstract]   [Full Text] [Related]  

  • 13. [Augmentation of antitumor immunity in cancer chemotherapy].
    Hosokawa M; Kobayashi H
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1402-6. PubMed ID: 1697151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A review of clinical tumor immunology. An approach to immunochemotherapy].
    Hattori T
    Nihon Gan Chiryo Gakkai Shi; 1974 Nov; 9(4):381-90. PubMed ID: 4616062
    [No Abstract]   [Full Text] [Related]  

  • 15. Genes coding for tumor rejection antigens: perspectives for specific immunotherapy.
    Boon T; Coulie P; Marchand M; Weynants P; Wölfel T; Brichard V
    Important Adv Oncol; 1994; ():53-69. PubMed ID: 8206495
    [No Abstract]   [Full Text] [Related]  

  • 16. Combination cancer therapy: Presidential address.
    Frei E
    Cancer Res; 1972 Dec; 32(12):2593-607. PubMed ID: 4118763
    [No Abstract]   [Full Text] [Related]  

  • 17. Preclinical evaluation of the interrelationships between cancer chemotherapy and immunity.
    Mihich E
    Natl Cancer Inst Monogr; 1971 Dec; 34():90-102. PubMed ID: 4400958
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
    Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
    Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Misonidazole enhancement of the action of BCNU and melphalan against human melanoma xenografts.
    Clutterbuck RD; Millar JL; McElwain TJ
    Am J Clin Oncol; 1982 Feb; 5(1):73-8. PubMed ID: 7081141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination chemotherapy for spontaneous AKR lymphoma.
    Schabel FM; Skipper HE; Trader MW; Laster WR; Cheeks JB
    Cancer Chemother Rep 2; 1974 Mar; 4(1):53-72. PubMed ID: 4499910
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 216.